Tenax Therapeutics To Discuss Third Quarter 2016 Financial Results And Provide Business Update

Published: Nov 04, 2016

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that the Company will host a conference call and live audio webcast on Thursday, November 10, 2016, at 8:30 a.m. ET to discuss its third quarter 2016 financial results and provide a business update.

Back to news